Article: Celoxib in preventing skin cancer.(Clinical Trial Review)(Brief Article)

This study is currently recruiting patients.

Sponsored by Herbert Irving Comprehensive Cancer Center, National Cancer Institute (NCI)

Celecoxib may be effective in preventing skin cancer by decreasing redness caused by exposure to ultraviolet light and changing potential skin cancer biomarkers. It is not yet known whether celecoxib is more effective than a placebo in preventing skin cancer. This is a Randomized phase II trial to study the effectiveness of celecoxib in preventing skin cancer in participants exposed to ultraviolet light.

 
Condition   Treatment or Intervention  Phase 
 
Basal Cell CarcinomaDrug: celecoxib  ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!